Rythmodan en es it fr

Rythmodan Brand names, Rythmodan Analogs

Rythmodan Brand Names Mixture

  • No information avaliable

Rythmodan Chemical_Formula

C21H29N3O

Rythmodan RX_link

http://www.rxlist.com/cgi/generic2/disopyr.htm

Rythmodan fda sheet

Rythmodan msds (material safety sheet)

Rythmodan Synthesis Reference

No information avaliable

Rythmodan Molecular Weight

339.475 g/mol

Rythmodan Melting Point

94.5-95 oC

Rythmodan H2O Solubility

44.9 mg/L

Rythmodan State

Solid

Rythmodan LogP

3.972

Rythmodan Dosage Forms

Capsule; Tablet (extended-release)

Rythmodan Indication

For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias.

Rythmodan Pharmacology

Disopyramide is an antiarrhythmic drug indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia that are life-threatening. In man, Disopyramide at therapeutic plasma levels shortens the sinus node recovery time, lengthens the effective refractory period of the atrium, and has a minimal effect on the effective refractory period of the AV node. Little effect has been shown on AV-nodal and His-Purkinje conduction times or QRS duration. However, prolongation of conduction in accessory pathways occurs.

Rythmodan Absorption

Nearly complete

Rythmodan side effects and Toxicity

LD50=580 mg/kg in rats

Rythmodan Patient Information

No information avaliable

Rythmodan Organisms Affected

Humans and other mammals